Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Antengene (6996 HK)
Watchlist
44
Analysis
Health Care
•
China
Antengene Corporation Limited operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Antengene
•
06 Nov 2020 07:40
Antengene: Gunning To Move Up in Line
This Insight provides an in-depth review of pre-revenue biotechnology Antegene that plans to list on the HKEX. We discuss the pipeline, market...
Kemp Dolliver, CFA
456 Views
Share
bullish
•
Antengene
•
04 Nov 2020 13:59
Antengene (德琪医药) Pre-IPO: Thoughts on Valuation
Antengene is a biotech company with a focus on in-licensed innovative oncology drugs. The company was founded by Dr Jay Mei, an ex-Celgene...
Ke Yan, CFA, FRM
Follow
363 Views
Share
bullish
•
Antengene
•
03 Nov 2020 17:43
Antengene IPO Initiation: Hunting for a Cure
Leveraging the management team’s expertise, Antegene focuses on the haematology and oncology therapeutic areas. Overall, we believe that Antegene’s...
Arun George
Follow
310 Views
Share
bullish
•
Ant Group
•
01 Nov 2020 11:23
ECM Weekly (1 November 2020) - Ant Group, Sunac Services, New Oriental HK, Bio-Thera
This week, much of the focus is on Ant whereas HK had a disappoint start with the poor debut of KWG Living and Shimao Services. On the other hand,...
Zhen Zhou, Toh
392 Views
Share
bullish
•
Ant Group
•
25 Oct 2020 11:14
ECM Weekly (25 October 2020) - Ant Group, Lufax, JW Thera, Shimao Svcs, GDS Secondary, Nanofilm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
Zhen Zhou, Toh
336 Views
Share
First
Previous
5
6
7
8
9
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x